The largest database of trusted experimental protocols

Kingfisher 96 magnetic particle processor

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Kingfisher 96 is a magnetic particle processor designed for automated nucleic acid purification. It utilizes magnetic separation technology to isolate and purify nucleic acids from a variety of sample types. The instrument is capable of processing up to 96 samples simultaneously, making it suitable for high-throughput applications.

Automatically generated - may contain errors

18 protocols using kingfisher 96 magnetic particle processor

1

PEDV RNA Extraction and Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
In brief, 90 μl of viral RNA was eluted from rectal swabs, fecal samples and oral fluid specimens using the Ambion® MagMAX™ viral RNA isolation kit (Life Technologies, Carlsbad CA USA) and a KingFisher® 96 magnetic particle processor (Thermo-Fisher Scientific) following the procedures provided by the manufacturers. Samples were tested for PEDV using a PEDV N gene-based rRT-PCR described in Madson et al. [7 (link)] and performed routinely at the Iowa State University-Veterinary Diagnostic Laboratory (ISU-VDL SOP 9.5263). The forward primer sequence was 5′-CGCAAAGACTGAACCCACTAACCT-3′, the reverse primer sequence was 5′-TTGCCTCTGTTGTTACTTGGAGAT-3′, and probe sequence was 5′-FAM-TGTTGCCAT/ZEN/TACCACGACTCCTGC-Iowa Black-3′. The eluted RNA, primers, and probe were mixed with commercial reagents TaqMan® Fast Virus 1-Step Master Mix (Life Technologies) and the rRT-PCR reactions were conducted on an ABI 7500 Fast instrument (Life Technologies) in fast mode as follows: 1 cycle at 50 °C for 5 min, 1 cycle at 95 °C for 20 s, 40 cycles at 95 °C for 3 s, and 60 °C for 30 s. The results were analyzed using an automatic baseline setting with a threshold at 0.1. Quantification cycle (Cq) values < 35 were considered positive for the corresponding coronavirus. Data were reported as ‘adjusted Cqs’: AdjustedCq=35sampleCq
+ Open protocol
+ Expand
2

Affinity Purification of snRNP Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytoplasmic extracts (2 mg/mL) from HeLa cells with individual knockdown were incubated with biotinylated snRNAs (10 nM) in the reconstitution buffer (20 mM HEPES, pH 7.9, 50 mM KCl, 5 mM MgCl2, 0.2 mM EDTA, 0.25 mg/mL yeast tRNAs (Sigma), protease inhibitor and 0.2 U/μL RNasin RNase inhibitor (Promega)) in 96-well plates (20 μL/well). Binding experiments were performed in cytoplasmic cell extracts at 4°C without addition of ATP to avoid Sm core assembly, which would occlude the Sm site. All reactions were carried out with gentle mixing at 750 rpm using the Thermomixer (Eppendorf) for 1 hr and RNA-protein complexes were captured by the M-280 streptavidin Dynabeads (Invitrogen) in 100 μL of RSB-150 buffer containing 0.02% Triton X-100, protease inhibitor and 0.2 U/μL RNase inhibitor for an additional hour. The beads were washed in RSB-200 buffer containing 0.02% Triton X-100 five times using the Kingfisher 96 magnetic particle processor (ThermoFischer Scientific), as previously described31 (link),32 (link). Bound proteins on the beads were eluted by boiling in 10 μL of 1X sample buffer, resolved by SDS-PAGE and detected by western blotting. Uncropped scans of western blots are provided in Supplementary Data Set 1.
+ Open protocol
+ Expand
3

FMDV Genome Quantification from Tissue Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two aliquots of each tissue sample collected at necropsy were thawed and individually macerated in tissue culture media, using a TissueLyser bead beater (Qiagen, Valencia, CA) and stainless steel beads (Qiagen cat. no. 69989). Total RNA was extracted from tissue macerates, serum, and OPF samples using Ambion’s MagMax-96 Viral RNA Isolation Kit (Ambion, Austin, TX) on a King Fisher-96 Magnetic Particle Processor (Thermo Scientific, Waltham, MA). Extracted RNA was analyzed using quantitative real-time RT-PCR (RT-qPCR), targeting the 3D region of the FMDV genome [40 (link)] with forward and reverse primers adapted from Rasmussen et al [41 (link)], and chemistry and cycling conditions as previously described [42 (link)]. Cycle threshold values were converted to FMDV RNA copies using an equation derived from analysis of serial 10-fold dilutions of in vitro synthesized FMDV RNA of known concentration. The equations of the curve of RNA copy numbers versus Ct values were further adjusted for the average mass of tissue samples and specific dilutions used during processing of samples.
+ Open protocol
+ Expand
4

FMDV cDNA Purification and Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FMDV P1 RT-PCR product was purified using a QIAquick® PCR Purification kit (Qiagen) according to manufacturer’s instructions. Purified FMDV cDNA was quantified using a NanoDrop 2000 spectrophotometer (Fisher Scientific, Pittsburg, PA, USA) and sequenced in 10 μl reactions containing 2 μl of BigDye® Terminator v3.1 (Applied Biosystems), 5 pmol of primer, and 15 ng of purified RT-PCR product as previously described [28 (link)]. Thermal cycling conditions consisted of 35 cycles of 10 s at 96 °C, 5 s at 50 °C, followed by 4 min at 60 °C. Sequencing products were purified on a Kingfisher 96 magnetic particle processor (Thermo Fisher Scientific) using a high-throughput the CleanSEQ kit (Agencourt). Nucleotide sequences were resolved using a 3730XL DNA sequencer (Applied Biosystems), and sequence contigs for each sample were compiled using the Sequencher® software (Gene Codes).
+ Open protocol
+ Expand
5

RNA Extraction from OPF Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
OPF samples in RNAlater® or in VTM prior to TTE treatment (N = 582) and all of the homogenized tissue samples (N = 57) were processed for RNA extraction. RNA was extracted using the MagMax-96 viral RNA isolation kit (Ambion, Austin, TX) following the manufacturers protocols on a King Fisher-96 Magnetic Particle Processor (Thermo Scientific, Waltham, MA). Briefly, 50 μl of each sample was added to 150 μl of lysis/binding solution in individual wells of a 96 well plate. After a lysis/binding step, the sample underwent four washes, a drying and a final elution step. RNA was eluted in a final volume of 25 μl of RNAase-free water. The extracted RNA was stored at −70°C until analyzed by real time reverse transcription PCR (rRT-PCR) as previously described (30 (link), 33 (link), 35 (link)). Samples were considered positive when Ct values were <40.
+ Open protocol
+ Expand
6

VSNJV RNA Extraction and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA extraction was carried out using Ambion’s MagMax-96 Viral RNA Isolation Kit (Ambion, Austin, TX, United States) on a King Fisher-96 Magnetic Particle Processor (Thermo Scientific Waltham, MA, United States) following a protocol previously described (Arzt et al., 2010 (link)). RNA (2.5 μl) was analyzed by real-time RT-PCR (rRT-PCR) targeting the VSNJV nucleocapsid gene (N), following a protocol previously described (Scherer et al., 2007 (link)). The only difference compared to the previously published protocol was a single nucleotide change introduced in the forward primer (5′-GCACTTCCTGATGGGAAATCA-3′) to match the sequence of the two viruses used in the current study. Reactions were performed with an ABI 7000 system (Applied Biosystems, Austin, TX, United States). Supplementary Figure S1 shows the test sensitivity for the detection of these two strains. Cycle threshold values were converted into RNA genome copy numbers per 2.5 μl of RNA by use of standard curves based on analysis of 10-fold dilutions of in vitro synthesized VSNJV N RNA.
+ Open protocol
+ Expand
7

Anthrax Lethal Factor Detection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemicals and reagents were purchased from Sigma-Aldrich (Saint Louis, MO) except where indicated. Dynabeads® MyOne Tosyl-activated magnetic beads were purchased from Invitrogen Co. (Carlsbad, CA). Recombinant LF (rLF) was purchased from List Biological Laboratories (Campbell, CA). Two non-neutralizing monoclonal anti-LF antibodies (LF-mAb) were prepared in the Division of Scientific Resources of CDC as previously described [19 (link)]. AIGIV was obtained from the Division of Strategic National Stockpile, CDC (Atlanta, GA). Pooled human donor plasma (n = 10 individuals per pool) (PH-plasma) and individual normal North American (NNA) donor serum and plasma samples were obtained from Interstate Blood Bank (Memphis, TN). Equipment included a Kingfisher 96 magnetic particle processor (Thermo Fisher Scientific., Waltham, MA), 4800 Plus Proteomics Analyzer (MALDI-TOF MS) (AB Sciex, Foster City, CA) and Gene Amp@ PCR thermocycler (ThermoFisher, Waltham, MA). All procedures and sample handling were conducted at Biosafety Level 2 containment as recommended and described [21 ]. Additional safety measures are described in each section as needed.
+ Open protocol
+ Expand
8

Quantification of FMDV RNA in Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
For antemortem samples (probangs), rRT-PCR was performed as described below without any other treatment. For postmortem samples (tissues), two specimens of each tissue listed in Table 2 were thawed and immediately macerated in a TissueLyser bead beater (Qiagen, Valencia, CA) as previously described [35 (link)]. For RNA extraction of probang samples and macerated tissues, 50 μl of each sample was transferred to a 96-well plate (Thermo Scientific, Waltham, MA) containing 150 μl lysis/binding solution. RNA was subsequently extracted using Ambion’s MagMax-96 Viral RNA Isolation Kit (Ambion, Austin, TX) on a King Fisher-96 Magnetic Particle Processor (Thermo Scientific, Waltham, MA). RNA was eluted in a final volume of 25 μl. Once extracted, 2.5 μl of RNA was analyzed by rRT-PCR on the ABI 7000 system (Applied Biosystems, Austin, TX) as previously described [35 (link)]. Samples with cycle threshold (Ct) values < 40 were considered positive. rRT-PCR results were converted to FMDV RNA copy numbers per mg of tissue as previously described [36 (link)]. The Ct positivity cutoff of 40 corresponded to a detection threshold value of 2.24 log10 FMDV RNA copies/mg (FMDV RNA/mg) of tissue. Real-time rRT-PCR results reported in Table 2 are the higher FMDV RNA/mg value of the two samples processed per tissue per animal.
+ Open protocol
+ Expand
9

Mycoplasma hyosynoviae Detection by qPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA extraction was performed using magnetic beads (MagMAX Total Nucleic Acid Isolation Kit; Applied Biosystems, USA) in a semi-automatic system (KingFisher 96 Magnetic Particle Processor; Thermo Fisher Scientific, USA) according to the manufacturer's instructions, after which samples were frozen at −20℃ until assayed for M. hyosynoviae by qPCR [3 (link)]. All clinical specimens including nasal swab, whole blood, serum, tonsil scraping, and synovial fluids or swabs were tested in duplicate for M. hyosynoviae by qPCR [3 (link)5 (link)19 (link)]. qPCR was also used to detect the presence (1) or absence (0), and to determine the M. hyosynoviae load per 2.5 µL of blood, serum, and joint samples [3 (link)].
+ Open protocol
+ Expand
10

Viral RNA Extraction from Fecal Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
In brief, 90 μl of viral RNA was eluted from sow fecal swab samples or 50 μl of piglet fecal:PBS sample (2.5.3 above) using the Ambion® MagMAX™ viral RNA isolation kit (Life Technologies) and a KingFisher® 96 magnetic particle processor (Thermo-Fisher Scientific) following the procedures provided by the manufacturers.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!